Varian Medical Systems Inc. (VAR)

127.94
2.57 1.97
NYSE : Health Technology
Prev Close 130.51
Open 128.00
Day Low/High 126.02 / 130.92
52 Wk Low/High 101.42 / 142.50
Volume 856.06K
Avg Volume 603.80K
Exchange NYSE
Shares Outstanding 90.95M
Market Cap 11.88B
EPS 1.60
P/E Ratio 31.52
Div & Yield N.A. (N.A)
Varian Announces Definitive Agreement To Acquire Cancer Treatment Services International

Varian Announces Definitive Agreement To Acquire Cancer Treatment Services International

Advances Varian Toward Being a Broad-Based Cancer Solutions Company; Updates Annual Guidance

Varian Announces Incremental Gross Impact Of New Tariffs

Varian Announces Incremental Gross Impact Of New Tariffs

PALO ALTO, Calif., May 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced preliminary estimates of the incremental gross impact of new tariffs.

Cyclotron For Varian ProBeam Compact Proton Therapy System Installed At New Treatment Center In Singapore

Cyclotron For Varian ProBeam Compact Proton Therapy System Installed At New Treatment Center In Singapore

PALO ALTO, Calif. and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte.

Papua New Guinea Hospital Selects Varian Cancer Care Solution

Papua New Guinea Hospital Selects Varian Cancer Care Solution

PALO ALTO, Calif., May 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it was selected by Port Moresby General Hospital (PMGH) in Papua New Guinea to equip its cancer treatment center with the Halcyon ™ radiotherapy system, as well as the ARIA...

Varian Acquires CyberHeart

Varian Acquires CyberHeart

Company Adds Technology for Cardiac Radioablation to Its Radiation Medicine Portfolio

Varian Selected To Equip Two Proton Therapy Centers In Norway

Varian Selected To Equip Two Proton Therapy Centers In Norway

PALO ALTO, Calif., May 9, 2019 /PRNewswire/ -- Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton therapy centers in Norway with the ProBeam ® multi-room...

Varian And Shandong Cancer Hospital Form Proton Therapy Clinical Application And Research Partnership In China

Varian And Shandong Cancer Hospital Form Proton Therapy Clinical Application And Research Partnership In China

PALO ALTO, Calif. and JINAN, China, May 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical application and research.

Varian To Attend Upcoming Investor Events

Varian To Attend Upcoming Investor Events

PALO ALTO, Calif., May 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will be attending the UBS Global Healthcare Conference ( May 20-22) and the 2019 RBC Capital Markets Healthcare Conference ( May 21-22) in New York City.

South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments With Varian Bravos Afterloader System

South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments With Varian Bravos Afterloader System

PALO ALTO, Calif. and CAPE TOWN, South Africa, April 30, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate (HDR) brachytherapy treatments with the...

Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments In Japan

Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments In Japan

PALO ALTO, Calif., April 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan is the first clinic in the country to begin treating cancer patients using the Halcyon ™ radiotherapy...

Varian Announces Global Clinical Consortium To Develop Evidence-based Protocols For Adaptive Radiotherapy

Varian Announces Global Clinical Consortium To Develop Evidence-based Protocols For Adaptive Radiotherapy

PALO ALTO, Calif., April 26, 2019 /PRNewswire/ -- Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based on clinical evidence, Varian (NYSE: VAR) today...

Varian Reports Results For Second Quarter Of Fiscal Year 2019

Varian Reports Results For Second Quarter Of Fiscal Year 2019

Raises Revenue Guidance for Fiscal Year 2019

First Varian Halcyon Treatments In Kenya Begin At Nairobi West Hospital

First Varian Halcyon Treatments In Kenya Begin At Nairobi West Hospital

PALO ALTO, Calif. and NAIROBI, Kenya, April 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that The Nairobi West Hospital in Nairobi, Kenya is the first clinic in the country and in West, Central, and East Africa to begin treating cancer...

Varian To Demonstrate Advanced Cancer Care Solutions At ESTRO 38

Varian To Demonstrate Advanced Cancer Care Solutions At ESTRO 38

PALO ALTO, Calif., April 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing its new single-room proton therapy system, ProBeam ® 360°, and the Bravos ™ afterloader system for High Dose Rate (HDR) brachytherapy treatments,...

Varian Installs Cyclotron For ProBeam Proton Therapy System At Hefei Ion Medical Center In China

Varian Installs Cyclotron For ProBeam Proton Therapy System At Hefei Ion Medical Center In China

PALO ALTO, Calif. and HEFEI, China, April 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam ® proton therapy system at Hefei Ion Medical Center (HIMC) in China.

Varian Opens Office In South Africa To Support Regional Growth

Varian Opens Office In South Africa To Support Regional Growth

PALO ALTO, Calif., April 4, 2019 /PRNewswire/ -- At a grand opening ceremony held March 8th, the Varian office in Hertford Office Park, Midrand, Johannesburg, South Africa was officially inaugurated.

Varian Discloses First Preclinical Results Of Potential Major Breakthrough In Cancer Treatment

Varian Discloses First Preclinical Results Of Potential Major Breakthrough In Cancer Treatment

Flash therapy preclinical results presented at AACR

Beacon Hospital Treats First Patient In Malaysia On Varian Halcyon System

Beacon Hospital Treats First Patient In Malaysia On Varian Halcyon System

PALO ALTO, Calif., April 2, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a 62-year-old male with thyroid cancer was the first patient in Malaysia to be treated on the Halcyon ™ system at Beacon Hospital in Selangor.

Korea University Medical Center Completes First Varian Halcyon System Treatment In Korea

Korea University Medical Center Completes First Varian Halcyon System Treatment In Korea

PALO ALTO, Calif. and SEOUL, South Korea, March 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a 55-year-old male with liver cancer at the Korea University Medical Center Anam Hospital, was the first patient in Korea to receive treatment on...

Varian Wins "Best After-Sales Service Award For Radiotherapy Products" In China Two Years In A Row

Varian Wins "Best After-Sales Service Award For Radiotherapy Products" In China Two Years In A Row

PALO ALTO, Calif. and BEIJING, March 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it again received the "Best After-Sales Service Award for Radiotherapy Products" in the 2018 Chinese Medical Devices Industry Data and After-Sales Service...

Varian Holds First Meeting Of FlashForward Consortium

Varian Holds First Meeting Of FlashForward Consortium

PALO ALTO, Calif., March 21, 2019 /PRNewswire/ -- Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian (NYSE: VAR) hosted the first meeting of the FlashForward ™ Consortium in Atlanta,...

Varian Announces Second Quarter Fiscal Year 2019 Earnings Release Date And Upcoming Investor Event

Varian Announces Second Quarter Fiscal Year 2019 Earnings Release Date And Upcoming Investor Event

PALO ALTO, Calif., March 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its second quarter fiscal year 2019 earnings release date and upcoming investor event.

Varian And Tata Trusts Sign Framework Agreement For Advanced Cancer Care Solutions To Address Growing Need In India

Varian And Tata Trusts Sign Framework Agreement For Advanced Cancer Care Solutions To Address Growing Need In India

PALO ALTO, Calif. and MUMBAI, India, March 11, 2019 /PRNewswire/ -- With an estimated 1.

Varian Medical Systems Becomes #185 Most Shorted S&P 500 Component, Replacing Dish Network

Varian Medical Systems Becomes #185 Most Shorted S&P 500 Component, Replacing Dish Network

The most recent short interest data has been released for the 02/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Varian-equipped NSIA-LUTH Cancer Treatment Centre In Nigeria Commissioned

Varian-equipped NSIA-LUTH Cancer Treatment Centre In Nigeria Commissioned

PALO ALTO, Calif. and IDI-ARABA, LAGOS, Nigeria, Feb.

Varian Demonstrating Smarter Cancer Care Solutions At HIMSS19

Varian Demonstrating Smarter Cancer Care Solutions At HIMSS19

PALO ALTO, Calif., Feb.

Varian Reports Results For First Quarter Of Fiscal Year 2019

Varian Reports Results For First Quarter Of Fiscal Year 2019

PALO ALTO, Calif., Jan.

TheStreet Quant Rating: B (Buy)